@incollection{,
	
					
					
					1EBE75E35DECB42E14BE4F0064CEEABF
					,
	note={Year 2015}
				,
	author={{ImaneOuziane} and {BensoudaY} and {HMrabtiMD} and {Elomrani FMD} and {Elismaili NMD} and {national institute of oncology}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}15218
}

@incollection{b0,
	
	
		,
	title={{Inflammatory breast cancer in Tunisia: epidemiological and clinical trends}}
		,
	author={{
			HBoussen
		} and {
			HBouzaiene
		} and {
			BenHassouna
		} and {
			JDhiab
		} and {
			TKhomsi
		} and {
			FBenna
		} and {
			F
		}}
		
		
		
		
		
		
	
	
		,
	journal={{Cancer}}
		
			116
			11
			
			,
	year={2010 Jun 1}
		
	
	,
	note={Suppl}

}

@incollection{b1,
	
	
		,
	title={{Epidemiologic features of rapidly progressing breast cancer in Tunisia}}
		,
	author={{
			NMourali
		} and {
			LRMuenz
		} and {
			FTabbane
		} and {
			SBelhassen
		} and {
			JBahi
		}}
		
		
		
		
	
	
		,
	journal={{Cancer}}
		
			46
			27412746
			,
	year={1980}
		
	

}

@incollection{b2,
	
	
		,
	title={{Inflammatory breast carcinoma incidence and survival}}
		,
	author={{
			ShineChang
		} and {
			SherylLParker
		} and {
			TuanPham
		} and {
			AmanUBuzdar
		} and {
			StephenDHursting
		}}
		
		
		
		
	
	
		,
	journal={{Cancer}}
		
			12
			12
			
			,
	year={1998}
		
	

}

@incollection{b3,
	
	
		,
	title={{Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute}}
		,
	author={{
			KWHance
		} and {
			WFAnderson
		} and {
			SSDevesa
		} and {
			HAYoung
		} and {
			PHLevine
		}}
		
		
		
		
	
	
		,
	journal={{J Natl Cancer Inst}}
		
			97
			13
			
			,
	year={2005 Jul 6}
		
	

}

@incollection{b4,
	
	
		,
	title={{Mouse mammary tumor virus-like sequences in human breast cancer}}
		,
	author={{
			JSLawson
		} and {
			WKGlenn
		} and {
			BSalmons
		} and {
			YYe
		} and {
			BHeng
		} and {
			PMoody
		}}
		
		
		
		
		
		10.1158/0008-5472.CAN-09-4160.Epub
	
	
		,
	journal={{Cancer Res}}
		
			70
			9
			
			,
	year={2010 May 1. 2010 Apr 13}
		
	

}

@book{b5,
	
	
		,
	title={{Defining the Clinical Diagnosis of Inflammatory Breast Cancer seminars in oncology}}
		,
	author={{
			ESingletary
		} and {
			MCristofanilli
		}}
		
		
			,
	year={February 2008}
			35
			
		
	

}

@incollection{b6,
	
	
		,
	title={{Epidemiology of inflammatory breast cancer}}
		,
	author={{
			WilliamFAnderson
		} and {
			CatherineSchairer
		} and {
			BingshuEChen
		} and {
			KennethWHance
		} and {
			PaulHLevine
		}}
		
		
		
		
	
	
		,
	journal={{Breast Disease. Breast Dis}}
		
			22
			
			,
	year={2005}
		
	

}

@incollection{b7,
	
	
		,
	title={{International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment}}
		,
	author={{
			SDawood
		} and {
			SDMerajver
		} and {
			PViens
		} and {
			PBVermeulen
		} and {
			SMSwain
		} and {
			TABuchholz
		}}
		
		
		
		
		
	
	
		,
	journal={{Ann Oncol}}
		
			22
			3
			
			,
	year={2011}
		
	

}

@book{b8,
	
	
		,
	title={{}}
		,
	author={{
			AParadiso
		} and {
			STommasi
		} and {
			MBrandi
		} and {
			Marzullo
		}}
		
		
		
		
	

}

@book{b9,
	
	
		,
	title={{Cell kinetics and hormonal receptor status in inflammatory breast carcinoma: Comparison with locally advanced disease Cancer}}
		,
	author={{
			F
		} and {
			SimoneG
		}}
		
		
			,
	year={1989 Nov 1}
			64
			
		
	

}

@incollection{b10,
	
	
		,
	title={{Inflammatory breast carcinoma and non-inflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?}}
		,
	author={{
			WFAnderson
		} and {
			KCChu
		} and {
			SChang
		}}
		
		
	
	
		,
	journal={{J Clin Oncol}}
		
			21
			
			,
	year={2003}
		
	

}

@book{b11,
	
	
		,
	title={{Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry BMC Cancer}}
		,
	author={{
			ABBenhammida
		} and {
			ISLabidi
		} and {
			KMrad
		} and {
			Charafe-Jauffret
		} and {
			EArab
		}}
		
		
		
		
		
			,
	year={2008}
			8
			28
		
	

}

@book{b12,
	
	
		,
	title={{Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients Breast Cancer Res Treat}}
		,
	author={{
			NChaher
		} and {
			HArias-Pulido
		} and {
			NTerki
		} and {
			CQualls
		} and {
			KBouzid
		} and {
			CVerschraegen
		}}
		
		
		
		
		
		
			,
	year={2012 Jan}
			131
			
		
	

}

@incollection{b13,
	
	
		,
	title={{Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance}}
		,
	author={{
			MGuerin
		} and {
			MGabillot
		} and {
			Mc Mathieu
		} and {
			MTravagli
		} and {
			Spielmann
		} and {
			Andrieu
		}}
		
		
		
		
		
		10.1002/ijc.v43:2/issuetoc
	
	
		,
	journal={{International Journal of Cancer}}
		
			43
			2
			
			,
	year={15 February 1989}
		
	

}

@book{b14,
	
	
		,
	title={{p53 Expression as a Prognostic Marker in Inflammatory Breast Cancer Clinical Cancer Res}}
		,
	author={{
			Gonzalez-Anguloam
		} and {
			Sneigen
		} and {
			AUBuzdar
		} and {
			VValero
		} and {
			MCristofallini
		}}
		
		
		
		
		
			,
	year={September 15. 2004 10}
			6215
		
	

}

@incollection{b15,
	
	
		,
	title={{}}
		,
	author={{
			CGKleer
		} and {
			KLVan Golen
		} and {
			TBraun
		} and {
			SDMerajver
		}}
		
		
		
	
	
		,
	journal={{Persistent E-Cadherin Expression in Inflammatory Breast Cancer Modern Pathoogy}}
		
			14
			5
			
			,
	year={2001}
		
	

}

@incollection{b16,
	
	
		,
	title={{Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression}}
		,
	author={{
			Cg Colpaert
		} and {
			Vermeulen
		} and {
			Benoy
		} and {
			Soubry
		} and {
			Van Roy
		}}
		
		
		
		
	
	
		,
	journal={{British Journal of Cancer}}
		
			88
			
			,
	year={2003}
		
	

}

@incollection{b17,
	
	
		,
	title={{A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory Breast cancer), and Rhoc GTPase correlate with the inflammatory breast cancer phenotype}}
		,
	author={{
			LKenneth
		} and {
			SeenaVan Golen
		} and {
			Davies
		} and {
			Zhi Fen
		} and {
			YunfangWu
		} and {
			CorazonDWang
		} and {
			HollyBucana
		} and {
			Root
		}}
		
		
		
		
		
		
		
	
	
		,
	journal={{Clin Cancer Res}}
		
			5
			9
			
			,
	year={1999}
		
	

}

@book{b18,
	
	
		,
	title={{Inflammatory Breast Cancer: What We Know and What We Need to Learn, The Oncologist}}
		,
	author={{
			HYamauchi
		} and {
			WAWoodward
		} and {
			VValero
		} and {
			RHAlvarez
		} and {
			ALucci
		} and {
			TABuchholz
		}}
		
		
		
		
		
		
			,
	year={July 2012vol}
			17
			
		
	

}

@incollection{b19,
	
	
		,
	title={{Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center}}
		,
	author={{
			TNaoto
		} and {
			AmanUUeno
		} and {
			SonjaEBuzdar
		} and {
			FrederickCSingletary
		} and {
			MarshaDAmes
		} and {
			Mcneese
		}}
		
		
		
		
		
	
	
		,
	journal={{Cancer Chemotherapy and Pharmacology}}
		
			40
			4
			
			,
	year={June 1997}
		
	

}

@incollection{b20,
	
	
		,
	title={{Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience}}
		,
	author={{
			MCristofanilli
		} and {
			AUGonzalez-Angulo
		} and {
			Buzdar
		} and {
			Sw Kau
		} and {
			Frye
		} and {
			Hortobagyi
		}}
		
		
		
		
		
	
	
		,
	journal={{Clin Breast Cancer}}
		
			4
			
			,
	year={2004}
		
	

}

@incollection{b21,
	
	
		,
	title={{Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone in patients with HER2-positif, locally advanced breast cancer,The NOAH trial}}
		,
	author={{
			LGianni
		} and {
			WEiermann
		} and {
			VSemiglazov
		} and {
			AManikhas
		} and {
			ALluch
		} and {
			STjulandin
		}}
		
		
		
		
		
	
	
		,
	journal={{Lancet}}
		
			375
			9712
			
			,
	year={2010 Jan 30}
		
	

}

@book{b22,
	
	
		,
	title={{Inflammatory Breast Cancer Determination of Prognostic Factors by Univariate and Multivariate Analysis. Cancer}}
		,
	author={{
			BChevallier
		} and {
			BAsselain
		} and {
			AKunlin
		} and {
			CVeyret
		} and {
			PBastit
		} and {
			YGraic
		}}
		
		
		
		
		
		10.1002/1097-0142(19870815)60:4%3C%3E1.0.CO;2-C/issuetoc
		
			,
	year={15 August 1987}
			60
			
		
	

}

@incollection{b23,
	
	
		,
	title={{Breast cancer response to neoadjuvant chemotherapy : predictive markers and relation with outcome}}
		,
	author={{
			IFFaneyte
		} and {
			JGSchrama
		} and {
			JLPeterse
		} and {
			PLRemijnse
		} and {
			SRodenhuis
		} and {
			MJVan De Vijver
		}}
		
		
		
		
		
	
	
		,
	journal={{Br J Cancer}}
		
			88
			
			,
	year={2003}
		
	

}

@incollection{b24,
	
	
		,
	title={{Neoadjuvant chemotherapy in 126 operable breast cancers}}
		,
	author={{
			EBelembaogo
		} and {
			Feillel
		} and {
			HChollet
		} and {
			Cure
		} and {
			Verrelle
		} and {
			Kwiatkowski
		}}
		
		
		
		
		
	
	
		,
	journal={{Eur J Cancer}}
		
			,
	year={1992}
		
	

}

@incollection{b25,
	
	
		,
	title={{Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicinebased neoadjuvant chemotherapy}}
		,
	author={{
			Kuerer
		} and {
			LANewman
		} and {
			TLSmith
		} and {
			FCAmes
		} and {
			KKHunt
		} and {
			KDhingra
		}}
		
		
		
		
		
	
	
		,
	journal={{J Clin Oncol}}
		
			17
			
			,
	year={1999}
		
	

}

@incollection{b26,
	
	
		,
	title={{Inflammatory breast cancer: the disease, the biology, the treatment}}
		,
	author={{
			FMRobertson
		} and {
			MBondy
		} and {
			WYang
		} and {
			HYamauchi
		} and {
			SWiggins
		} and {
			SKamrudin
		}}
		
		
		
		
		
	
	
		,
	journal={{CA Cancer J Clin}}
		
			60
			6
			
			,
	year={2010 Nov-Dec}
		
	

}

@incollection{b27,
	
	
		,
	title={{Microvessel density, expression of oestrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast Cancer}}
		,
	author={{
			Cg
		} and {
			PBVermeulen
		} and {
			LYDirix
		} and {
			EAVan Marck
		}}
		
		
		
	
	
		,
	journal={{Clin Cancer Res}}
		
			9
			10
			
			,
	year={2003 Sep 1}
		
	
	,
	note={Pt 1}

}

@incollection{b28,
	
	
		,
	title={{Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study}}
		,
	author={{
			JYPierga
		} and {
			TPetit
		} and {
			TDelozier
		} and {
			JMFerrero
		} and {
			MCampone
		} and {
			JGligorov
		}}
		
		
		
		
		
	
	
		,
	journal={{Lancet Oncol}}
		
			13
			4
			
			,
	year={2012 Apr}
		
	

}

@incollection{b29,
	
	
		,
	title={{ALK gene amplified in most inflammatory breast cancers}}
		,
	author={{
			SRabiya
		} and {
			Tuma
		}}
		
	
	
		,
	journal={{JNCI J Natl Cancer Inst}}
		
			104
			2
			
			,
	year={2012}
		
	

}